Cargando…
Multiscale modelling of drug transport and metabolism in liver spheroids
In early preclinical drug development, potential candidates are tested in the laboratory using isolated cells. These in vitro experiments traditionally involve cells cultured in a two-dimensional monolayer environment. However, cells cultured in three-dimensional spheroid systems have been shown to...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061947/ https://www.ncbi.nlm.nih.gov/pubmed/32194929 http://dx.doi.org/10.1098/rsfs.2019.0041 |
_version_ | 1783504467498369024 |
---|---|
author | Leedale, Joseph A. Kyffin, Jonathan A. Harding, Amy L. Colley, Helen E. Murdoch, Craig Sharma, Parveen Williams, Dominic P. Webb, Steven D. Bearon, Rachel N. |
author_facet | Leedale, Joseph A. Kyffin, Jonathan A. Harding, Amy L. Colley, Helen E. Murdoch, Craig Sharma, Parveen Williams, Dominic P. Webb, Steven D. Bearon, Rachel N. |
author_sort | Leedale, Joseph A. |
collection | PubMed |
description | In early preclinical drug development, potential candidates are tested in the laboratory using isolated cells. These in vitro experiments traditionally involve cells cultured in a two-dimensional monolayer environment. However, cells cultured in three-dimensional spheroid systems have been shown to more closely resemble the functionality and morphology of cells in vivo. While the increasing usage of hepatic spheroid cultures allows for more relevant experimentation in a more realistic biological environment, the underlying physical processes of drug transport, uptake and metabolism contributing to the spatial distribution of drugs in these spheroids remain poorly understood. The development of a multiscale mathematical modelling framework describing the spatio-temporal dynamics of drugs in multicellular environments enables mechanistic insight into the behaviour of these systems. Here, our analysis of cell membrane permeation and porosity throughout the spheroid reveals the impact of these properties on drug penetration, with maximal disparity between zonal metabolism rates occurring for drugs of intermediate lipophilicity. Our research shows how mathematical models can be used to simulate the activity and transport of drugs in hepatic spheroids and in principle any organoid, with the ultimate aim of better informing experimentalists on how to regulate dosing and culture conditions to more effectively optimize drug delivery. |
format | Online Article Text |
id | pubmed-7061947 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Royal Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-70619472020-03-19 Multiscale modelling of drug transport and metabolism in liver spheroids Leedale, Joseph A. Kyffin, Jonathan A. Harding, Amy L. Colley, Helen E. Murdoch, Craig Sharma, Parveen Williams, Dominic P. Webb, Steven D. Bearon, Rachel N. Interface Focus Articles In early preclinical drug development, potential candidates are tested in the laboratory using isolated cells. These in vitro experiments traditionally involve cells cultured in a two-dimensional monolayer environment. However, cells cultured in three-dimensional spheroid systems have been shown to more closely resemble the functionality and morphology of cells in vivo. While the increasing usage of hepatic spheroid cultures allows for more relevant experimentation in a more realistic biological environment, the underlying physical processes of drug transport, uptake and metabolism contributing to the spatial distribution of drugs in these spheroids remain poorly understood. The development of a multiscale mathematical modelling framework describing the spatio-temporal dynamics of drugs in multicellular environments enables mechanistic insight into the behaviour of these systems. Here, our analysis of cell membrane permeation and porosity throughout the spheroid reveals the impact of these properties on drug penetration, with maximal disparity between zonal metabolism rates occurring for drugs of intermediate lipophilicity. Our research shows how mathematical models can be used to simulate the activity and transport of drugs in hepatic spheroids and in principle any organoid, with the ultimate aim of better informing experimentalists on how to regulate dosing and culture conditions to more effectively optimize drug delivery. The Royal Society 2020-04-06 2020-02-14 /pmc/articles/PMC7061947/ /pubmed/32194929 http://dx.doi.org/10.1098/rsfs.2019.0041 Text en © 2020 The Authors. http://creativecommons.org/licenses/by/4.0/ Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, provided the original author and source are credited. |
spellingShingle | Articles Leedale, Joseph A. Kyffin, Jonathan A. Harding, Amy L. Colley, Helen E. Murdoch, Craig Sharma, Parveen Williams, Dominic P. Webb, Steven D. Bearon, Rachel N. Multiscale modelling of drug transport and metabolism in liver spheroids |
title | Multiscale modelling of drug transport and metabolism in liver spheroids |
title_full | Multiscale modelling of drug transport and metabolism in liver spheroids |
title_fullStr | Multiscale modelling of drug transport and metabolism in liver spheroids |
title_full_unstemmed | Multiscale modelling of drug transport and metabolism in liver spheroids |
title_short | Multiscale modelling of drug transport and metabolism in liver spheroids |
title_sort | multiscale modelling of drug transport and metabolism in liver spheroids |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061947/ https://www.ncbi.nlm.nih.gov/pubmed/32194929 http://dx.doi.org/10.1098/rsfs.2019.0041 |
work_keys_str_mv | AT leedalejosepha multiscalemodellingofdrugtransportandmetabolisminliverspheroids AT kyffinjonathana multiscalemodellingofdrugtransportandmetabolisminliverspheroids AT hardingamyl multiscalemodellingofdrugtransportandmetabolisminliverspheroids AT colleyhelene multiscalemodellingofdrugtransportandmetabolisminliverspheroids AT murdochcraig multiscalemodellingofdrugtransportandmetabolisminliverspheroids AT sharmaparveen multiscalemodellingofdrugtransportandmetabolisminliverspheroids AT williamsdominicp multiscalemodellingofdrugtransportandmetabolisminliverspheroids AT webbstevend multiscalemodellingofdrugtransportandmetabolisminliverspheroids AT bearonracheln multiscalemodellingofdrugtransportandmetabolisminliverspheroids |